# A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)

> **NCT00337558** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 643 (actual)

## Conditions studied

- Overactive Bladder
- Urinary Incontinence
- Urge Incontinence

## Interventions

- **DRUG:** Solifenacin succinate
- **BEHAVIORAL:** Simplified bladder training

## Key facts

- **NCT ID:** NCT00337558
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 643 (ACTUAL)
- **Last updated:** 2014-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337558, "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00337558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*